Oric Pharmaceuticals/$ORIC
About Oric Pharmaceuticals
Ticker
Industry
Employees
ORIC Metrics
$607M
-
-$1.80
1.12
-
Price and volume
Market cap
$607M
Beta
1.12
52-week high
$16.65
52-week low
$6.33
Average daily volume
413K
Financial strength
Current ratio
13.151
Quick ratio
12.819
Long term debt to equity
2.492
Total debt to equity
3.631
Management effectiveness
Return on assets (TTM)
-29.22%
Return on equity (TTM)
-45.98%
Valuation
Price to book
2.21
Price to tangible book (TTM)
2.21
Price to free cash flow (TTM)
-5.199
Growth
Earnings per share change (TTM)
-8.84%
3-year earnings per share growth (CAGR)
-7.84%
What the Analysts think about ORIC
Analyst Ratings
ORIC Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
ORIC Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
ORIC News
ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones
ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
FAQs
What’s the current market cap for Oric Pharmaceuticals stock?
What is the P/E ratio for Oric Pharmaceuticals stock?
Does Oric Pharmaceuticals stock pay dividends?
No, Oric Pharmaceuticals (ORIC) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Oric Pharmaceuticals dividend payment date?
Oric Pharmaceuticals (ORIC) stock does not pay dividends to its shareholders.
What is the beta indicator for Oric Pharmaceuticals?
Oric Pharmaceuticals (ORIC) has a beta rating of 1.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.